A detailed history of Peak6 Investments LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Peak6 Investments LLC holds 54,500 shares of BBIO stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,500
Previous 17,500 211.43%
Holding current value
$1.28 Million
Previous $443,000 213.09%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$23.0 - $31.04 $111,895 - $151,009
-4,865 Reduced 20.32%
19,082 $483,000
Q1 2024

May 14, 2024

BUY
$27.35 - $40.45 $326,941 - $483,539
11,954 Added 99.67%
23,947 $740,000
Q4 2023

Feb 13, 2024

BUY
$24.02 - $43.89 $117,505 - $214,709
4,892 Added 68.89%
11,993 $484,000
Q3 2023

Nov 13, 2023

SELL
$16.89 - $35.01 $48,964 - $101,493
-2,899 Reduced 28.99%
7,101 $187,000
Q2 2023

Aug 11, 2023

BUY
$13.29 - $18.01 $132,900 - $180,100
10,000 New
10,000 $172,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.47B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.